| The importance of studying inherited hematological disorders in ancient Anatolian populations | Yeşim ALAKOÇ DOĞAN,Nejat AKAR | 257–263 |
| Beta-globin gene mutations in children with beta-thalassemia major from Şanlıurfa province, Turkey | ALİ AYÇİÇEK,AHMET KOÇ,ZEYNEP CANAN ÖZDEMİR,Hasan BİLİNÇ,ABDÜRRAHİM KOÇYİĞİT,FUAT DİLMEÇ | 264–268 |
| Tracing the footsteps of IVS-I-130 G-C mutation of the human hemoglobin beta globin gene: From Şanlıurfa to Askeriye, Burdur, Turkey | Çiğdem ALTAY | 269–270 |
| İnsan hemoglobin beta globin genindeki IVS-I-130 G-C mutasyonu izlerinin takibi: Şanlıurfa'dan Askeriye'ye, Burdur, Türkiye | Çiğdem ALTAY | 269–270 |
| Antifungal prophylaxis in stem cell transplantation centers in Turkey | HAMDİ AKAN | 271–275 |
| The effects of Ankaferd® Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile | SERKAN YILMAZ,ŞÜKRÜ GÜLEÇ,DİDEM TORUN,İbrahim Celalettin HAZNEDAROĞLU,Nejat AKAR | 276–285 |
| Long-term outcome in children with nutritional vitamin B12 deficiency | Melike Sezgin EVİM,ŞAHİN ERDÖL,Özlem ÖZDEMİR,Birol BAYTAN,Adalet Meral GÜNEŞ | 286–293 |
| Clinical investigation of oral findings in inherited disorders of platelet function | MÜJGAN GÜNGÖR HATİPOĞLU,Yahya BÜYÜKAŞIK,Özden KANSU | 294–298 |
| Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients | Tawhida Y. Abdel GHAFFAR, M. Solaf ELSAYED, A. Mohamed SAKR, S. Ezzat ELSOBKY, M. Sara ABDELHAKAM, Said YOUSUF, Nejat AKAR, Yonca EĞİN | 299–305 |
| Factor V G1691A (Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders | Nur SOYER,Ali Şahin KÜÇÜKARSLAN,Fahri ŞAHİN,Demet ÇEKDEMİR,BUKET KOSOVA,FATMA ZUHAL EROĞLU,Mahmut TÖBÜ,MURAT TOMBULOĞLU,Seçkin ÇAĞIRGAN,Ayhan DÖNMEZ,Filiz VURAL,Güray SAYDAM | 306–311 |
| Plasmacytoid dendritic cell tumor: A case report | Fürüzan DÖĞER KAÇAR,Emel ÇETİN DİKİCİOĞLU,Mine HEKİMGİL,Meltem USLU ÖZDOĞAN,Gürhan KADIKÖYLÜ,Nazan ÖZSAN,Ekin ŞAVK,Zahit BOLAMAN |